1-3 of 3
Marion Macey, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Inter-Laboratory Assessment of Minimal Residual Disease In Chronic Lymphocytic Leukemia – Evaluation of the Novel CD160FCA Assay

Timothy Farren, BSc(HONS), MIBMS, Fengting Liu, MD, PhD, Claire Stephens, MSc, Marion Macey, PhD, FRCPath, Michael Jenner, MD, PhD, FRCPath, Archie Prentice, MB, FRCP, FRCPath, Amit Nathwani, MBChB, FRCP, FRCPath, Samir Agrawal, MD, PhD, FRCPath
Journal: Blood
Blood (2010) 116 (21): 2723.
https://doi.org/10.1182/blood.V116.21.2723.2723
Published: 2010
Journal Articles

Using CD160 as a Novel Approach to the Assessment of Minimal Residual Disease (MRD) in Chronic Lymphocytic Leukaemia (CLL).

Timothy Farren, BSc (Hons), Jerome Giustiniani, PhD, Ulrika Johansson, PhD, Christina Lim, RN, Gemma Athorn, MSc, Adrian Newland, MD, Marion Macey, PhD, Samir Agrawal, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 2036.
https://doi.org/10.1182/blood.V110.11.2036.2036
Published: 2007
Journal Articles

High Frequency of Surface Immunoglobulin IgG in B-Cell Chronic Lymphocytic Leukaemia.

Catherine Wiseman, BSc, Jerome Giustiniani, PhD, Lene Mikkelsen, MSc, Marion Macey, PhD, Lindsey Goff, PhD, John Gribben, MD, PhD, Samir Agrawal, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 4685.
https://doi.org/10.1182/blood.V110.11.4685.4685
Published: 2007